HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 516951Erstellt: 27. Oktober 2026
Phosphorsure, Kaliumsalz
phosphoric acid, potassium salt · phosphoric acid potassium salt,>97% · Phosphoric acid, potassium salt (1:)
https://huagongshe.com/de/chemical/516951
Identifikatoren & physikalische Daten
| CAS No. | 16068-46-5 |
|---|
| Summenformel | KH2PO4 |
|---|
| Durchschnittliche Molmasse | 136,086 g/mol |
|---|
| Monoisotopische Masse | 135,93277685 g/mol |
|---|
| SMILES | O=P([O-])(O)O.[K+] |
|---|
| InChIKey | GNSKLFRGEWLPPA-UHFFFAOYSA-M |
|---|
| PubChem CID | 516951 |
|---|
| ChEMBL | CHEMBL1200925 |
|---|
| ChEBI | CHEBI:63036 |
|---|
| EC No. | 231-913-4 |
|---|
| DTXSID | DTXSID0035667 |
|---|
| Lokaler Name | Phosphorsure, Kaliumsalz |
|---|
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 80,6 |
|---|
| H-Brücken-Donoren | 2 |
|---|
| H-Brücken-Akzeptoren | 4 |
|---|
| Frei drehbare Bindungen | 0 |
|---|
| Schwere Atome | 6 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 61,9 |
|---|
| Stoffklassen | Metals -> Phosphates, Metallic Salts |
|---|
| Kosmetika | Cosmetic ingredients (Potassium Phosphate) -> CIR (Cosmetic Ingredient Review)Buffering |
|---|
| pH | Between 4,2 and 4,8 (1 % solution)pH = 4.4 to 4.7 |
|---|
| SpringerMaterials Properties | thermal expansion coefficient |
|---|
| Geruch | Odorless |
|---|
| Lebensmittelzusatzstoffe | MALTING OR FERMENTING AID, NUTRIENT SUPPLEMENT, PH CONTROL AGENT, STABILIZER OR THICKENER -> FDA Substance added to food |
|---|
| Dichte | 2.34 g/cu cm2.34 g/cm³ |
|---|
| Color/Form | Colorless crystals or white granular powderWhite tetragonal crystals |
|---|
| Löslichkeit | Freely soluble in water. Insoluble in ethanolSolubility: 18 g/100g water /Monopotassium phosphate anhydrous/Soluble in about 4.5 parts waterinsoluble in alcoholSolubility: 25 g/100 cc water at 25 °C. Slightly soluble in ethanolSolubility in water, g/100ml: 22 |
|---|
| Human Drugs | FDA approved drugs -> Active ingredient |
|---|
| Animal Drugs | Active Ingredients (Potassium Phosphate) -> FDA Greenbook |
|---|
| Schmelzpunkt | 253 °C |
|---|
| Kosmetik-Inhaltsstoffe Funktionen | BUFFERING |
|---|
| EPA chemische Informationen | Phosphoric acid, potassium salt (16068-46-5) |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 90.7% (794 of 875) of all reports.Not ClassifiedAggregated GHS information provided per 875 reports by companies from 16 notifications to the ECHA C&L Inventory. |
|---|
| Regulatorische Informationen | Chemical: Phosphoric acid, monopotassium saltPhosphoric acid, potassium salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Phosphoric acid, potassium salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Phosphoric acid, potassium salt (1:?) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Phosphoric acid, potassium salt (1:?) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Status: Active Update: 11-04-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/15471Potassium phosphate, monobasic: Does not have an individual approval but may be used under an appropriate group standard |
|---|
| Weitere Sicherheitsinformationen | IMAP assessments - Phosphoric acid, monopotassium salt: Environment tier I assessment |
|---|
| Brandgefahren | Not combustible. Gives off irritating or toxic fumes (or gases) in a fire. |
|---|
| Gefahrenübersicht | A skin, eye, and respiratory tract irritant[ICSC] Emergency treatment: Inorganic phosphatesInorganic phosphates can cause diarrhea, hyperphosphatemia, and hypocalcemia after ingestionAn adult died after receiving four sodium phosphate enemas within 24 hourshe had electrolyte abnormalities and died from cardiac arrest[HSDB] |
|---|
| FDA-Anforderungen | The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl potassium phosphate, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.Potassium phosphates (mono, di, and tribasic) are indirect food additives for use only as components of adhesives. |
|---|